Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01935583 · ClinicalTrials.gov registry record · NA
Intervention to Promote Survivor Resilience and Adjustment: Efficacy Evaluation
A NA study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
NCT01935583: Completed NA study, sponsored by Virginia Commonwealth University.
NCT01935583 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 164 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01935583, a NA study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
Study Summary
1. To evaluate the short and longer-term efficacy of a structured outpatient intervention program (The Resilience and Adjustment Intervention, RAI) to improve survivors' resilience. 2. To evaluate the impact of treatment on emotional well-being and postinjury adjustment. 3. To evaluate the impact of the intervention on abilities including problem solving, communication, and stress management. 4. To examine the extent to which treatment benefits are sustained in the longer-term.
Primary Outcome
During the past decade, researchers have developed resilience measurement scales, and a recent review suggested that Connor and Davidson have been most successful. The authors first developed a 25 item scale (CD-RISC) reflecting resilience characteristics identified by Kobasa and Rutter. Normative studies including factor analyses indicated that the CD-RISC is reliable, valid, and sensitive to treatment effects. More recently, a 10-item version was developed using exploratory and confirmatory fa
Interventions
- BEHAVIORAL Resilience/Adjustment Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2013-01 |
| Est. Completion | 2017-09-30 |
| Phase | NA |
What the finished NCT01935583 record still lists
NCT01935583 is an interventional study that assigns participants to a tested intervention. The registered 164 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 1 intervention - of which Resilience/Adjustment Counseling is the first listed.
NCT01935583 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01935583 about?
NCT01935583 is a clinical study titled "Intervention to Promote Survivor Resilience and Adjustment: Efficacy Evaluation". 1. To evaluate the short and longer-term efficacy of a structured outpatient intervention program (The Resilience and Adjustment Intervention, RAI) to improve survivors' resilience. 2. To evaluate the impact of treatment on emotional well-being and postinjury adjustment. 3. To evaluate the impact of...
What is the current status of trial NCT01935583?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2013-01. Estimated completion is 2017-09-30.
What interventions are being tested in trial NCT01935583?
The interventions under investigation include: Resilience/Adjustment Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01935583?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01935583's enrollment target sits among peer trials
164 626th of 2000 higher than 1,374 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04891289 · 164 participants · Phase 2
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
- NCT04893226 · 164 participants · NA
Time-Restricted Feeding Intervention in Metabolically-Unhealthy Postmenopausal Women
- NCT05270213 · 164 participants · Phase 1
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
- NCT05543681 · 164 participants · Phase 2
Clinical Trial on Agitation in Alzheimer's Dementia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia